Patterns Of Antiretroviral Nonadherence
Edward M Gardner
Denver Health And Hospital Authority
Grant 5K01AI067063-05 from National Institute Of Allergy And Infectious Diseases, IRG: AIDS
Abstract: CANDIDATE Dr. Gardner is finishing his research fellowship in infectious diseases at the University of Colorado Health Sciences Center and Denver Public Health. He plans a career as an independent investigator, educator, and clinician in academic infectious diseases. Dr. Gardner´s research career development plan includes obtaining an M.S.P.H. degree. He will obtain additional education in behavioral and qualitative research, and questionnaire design. ENVIRONMENT The research will be conducted at Denver Health, a major care provider for HIV-infected persons in Denver, Colorado. The mentor and co-mentors have extensive experience in epidemiological and clinical research and statistical analysis, have competed successfully for independent funding, and have trained successful researchers and clinicians. BACKGROUND Antiretroviral adherence has been studied for over 10 years, but generally using a single summary statistic (percent adherence) to summarize adherence behavior. We hypothesize that specific patterns of nonadherence - selective drug taking, frequent missed doses, prolonged periods of time off therapy - can be identified with more detailed study of adherence behavior. A deeper understanding of nonadherence may lead to the development of targeted and durable adherence interventions. The cost of some adherence interventions may be a barrier to their implementation, but the costs associated with poor adherence have not been well studied. SPECIFIC AIMS 1) to examine pharmacy refill data to acquire a detailed understanding of patterns of nonadherence to antiretrovirals in an unselected clinic population, 2) to apply hypotheses generated through retrospective analysis to prospectively obtained data from clinical trials, 3) to understand the behaviors and system-level barriers which bring about different patterns of pharmacy refills, and 4) to assess the association of antiretroviral adherence with utilization and costs of health care. RELEVANCE This research aims to understand the barriers that are present within individuals and within the healthcare system that may lead to a failure to take antiretroviral medications as prescribed. It will help clinicians and policy makers understand the association of antiretroviral adherence with the cost of care. If poor adherence to therapy is associated with increased costs of care, clinicians, researchers, and policy makers may be more willing to devote resources to the development of effective adherence interventions
Keywords: AIDS therapy, antiAIDS agent, cost effectiveness, health care cost /financing, therapy compliance HIV infection, drug resistance, health care service utilization, longitudinal human study behavioral /social science research tag, clinical research, focus group, human data, human subject, interview
Project start date: 2005-09-17
Project end date: 2010-07-31
Sponsored Links Lab Supply Mall http://www.labsupplymall.com
Patterns Of Antiretroviral Nonadherence
Edward M Gardner
Denver Health And Hospital Authority Denver, Co 802044507
Grant 5K01AI067063-04 from National Institute Of Allergy And Infectious Diseases, IRG: AIDS
Abstract: CANDIDATE Dr. Gardner is finishing his research fellowship in infectious diseases at the University of Colorado Health Sciences Center and Denver Public Health. He plans a career as an independent investigator, educator, and clinician in academic infectious diseases. Dr. Gardner s research career development plan includes obtaining an M.S.P.H. degree. He will obtain additional education in behavioral and qualitative research, and questionnaire design. ENVIRONMENT The research will be conducted at Denver Health, a major care provider for HIV-infected persons in Denver, Colorado. The mentor and co-mentors have extensive experience in epidemiological and clinical research and statistical analysis, have competed successfully for independent funding, and have trained successful researchers and clinicians. BACKGROUND Antiretroviral adherence has been studied for over 10 years, but generally using a single summary statistic (percent adherence) to summarize adherence behavior. We hypothesize that specific patterns of nonadherence - selective drug taking, frequent missed doses, prolonged periods of time off therapy - can be identified with more detailed study of adherence behavior. A deeper understanding of nonadherence may lead to the development of targeted and durable adherence interventions. The cost of some adherence interventions may be a barrier to their implementation, but the costs associated with poor adherence have not been well studied. SPECIFIC AIMS 1) to examine pharmacy refill data to acquire a detailed understanding of patterns of nonadherence to antiretrovirals in an unselected clinic population, 2) to apply hypotheses generated through retrospective analysis to prospectively obtained data from clinical trials, 3) to understand the behaviors and system-level barriers which bring about different patterns of pharmacy refills, and 4) to assess the association of antiretroviral adherence with utilization and costs of health care. RELEVANCE This research aims to understand the barriers that are present within individuals and within the healthcare system that may lead to a failure to take antiretroviral medications as prescribed. It will help clinicians and policy makers understand the association of antiretroviral adherence with the cost of care. If poor adherence to therapy is associated with increased costs of care, clinicians, researchers, and policy makers may be more willing to devote resources to the development of effective adherence interventions.
Keywords: AIDS therapy, antiAIDS agent, cost effectiveness, health care cost /financing, therapy compliance, HIV infection, drug resistance, health care service utilization, longitudinal human study, behavioral /social science research tag, clinical research, focus group, human data, human subject, interview
Project start date: 2005-09-17
Project end date: 2010-07-31
5K01AI067063-04 (2007): $129511
5K01AI067063-03 (2006): $131308
Grants awarded to Edward M Gardner
Patterns Of Antiretroviral Nonadherence
Edward M Gardner
Denver Health And Hospital Authority Denver, Co 802044507
Grant 7K01AI067063-02 from National Institute Of Allergy And Infectious Diseases, IRG: AIDS
Abstract: CANDIDATE Dr. Gardner is finishing his research fellowship in infectious diseases at the University of Colorado Health Sciences Center and Denver Public Health. He plans a career as an independent investigator, educator, and clinician in academic infectious diseases. Dr. Gardner s research career development plan includes obtaining an M.S.P.H. degree. He will obtain additional education in behavioral and qualitative research, and questionnaire design. ENVIRONMENT The research will be conducted at Denver Health, a major care provider for HIV-infected persons in Denver, Colorado. The mentor and co-mentors have extensive experience in epidemiological and clinical research and statistical analysis, have competed successfully for independent funding, and have trained successful researchers and clinicians. BACKGROUND Antiretroviral adherence has been studied for over 10 years, but generally using a single summary statistic (percent adherence) to summarize adherence behavior. We hypothesize that specific patterns of nonadherence - selective drug taking, frequent missed doses, prolonged periods of time off therapy - can be identified with more detailed study of adherence behavior. A deeper understanding of nonadherence may lead to the development of targeted and durable adherence interventions. The cost of some adherence interventions may be a barrier to their implementation, but the costs associated with poor adherence have not been well studied. SPECIFIC AIMS 1) to examine pharmacy refill data to acquire a detailed understanding of patterns of nonadherence to antiretrovirals in an unselected clinic population, 2) to apply hypotheses generated through retrospective analysis to prospectively obtained data from clinical trials, 3) to understand the behaviors and system-level barriers which bring about different patterns of pharmacy refills, and 4) to assess the association of antiretroviral adherence with utilization and costs of health care. RELEVANCE This research aims to understand the barriers that are present within individuals and within the healthcare system that may lead to a failure to take antiretroviral medications as prescribed. It will help clinicians and policy makers understand the association of antiretroviral adherence with the cost of care. If poor adherence to therapy is associated with increased costs of care, clinicians, researchers, and policy makers may be more willing to devote resources to the development of effective adherence interventions.
Keywords: AIDS therapy, antiAIDS agent, cost effectiveness, health care cost /financing, therapy compliance, HIV infection, drug resistance, health care service utilization, longitudinal human study, behavioral /social science research tag, clinical research, focus group, human data, human subject, interview
Project start date: 2005-09-17
Project end date: 2010-07-31
1K01AI067063-01 (2005): $131820
Related Publications
Mild-to-moderate symptoms during the first year of antiretroviral therapy worsen quality of life in HIV-infected individuals. Clin Infect Dis. 2008 Mar 15; 46( 6): 941-5. PMID: 18279044 Clostridium butyricum sepsis in an injection drug user with an indwelling central venous catheter. J Med Microbiol. 2008 Feb; 57( Pt 2): 236-9. PMID: 18201992 Differential adherence to combination antiretroviral therapy is associated with virological failure with resistance. AIDS. 2008 Jan 2; 22( 1): 75-82. PMID: 18090394 
Durability of adherence to antiretroviral therapy on initial and subsequent regimens. AIDS Patient Care STDS. 2006 Sep; 20( 9): 628-36. PMID: 16987049 Risk-based human immunodeficiency virus (HIV) testing fails to detect the majority of HIV-infected persons in medical care Settings. Sex Transm Dis. 2006 May; 33( 5): 329-33. PMID: 16547450 Selective drug taking during combination antiretroviral therapy in an unselected clinic population. J Acquir Immune Defic Syndr. 2005 Nov 1; 40( 3): 294-300. PMID: 16249703 Conventional and molecular epidemiology of macrolide resistance among new Mycobacterium avium complex isolates recovered from HIV-infected patients. Clin Infect Dis. 2005 Oct 1; 41( 7): 1041-4. Epub 2005 Aug 25. PMID: 16142672 
A middle-aged woman with recurrent respiratory infections. Respiration. 2005 Jul-Aug; 72( 4): 427-30. No abstract available. PMID: 16088289 Illness of Immune Reconstitution: Recognition and Management. Curr Infect Dis Rep. 2004 Dec; 6( 6): 483-493. PMID: 15538986